REMEDY KOMPLEMENTAR APS: Financial statements 2024
CVR: 43993577
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
REMEDY KOMPLEMENTAR APS (CVR 43993577) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,125 and a net result of DKK 1,377. Equity in the 2024 report amounted to DKK 41,118. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 1,125
- Profit/Loss
- DKK 1,377
- Equity
- DKK 41,118
- Total Assets
- DKK 41,118
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of July 11, 2024, Mikkel Mirsbach Rasmussen is registered as director of REMEDY KOMPLEMENTAR APS.
As of July 11, 2024, Steffen Ulsø Knudsen is registered as an owner of REMEDY KOMPLEMENTAR APS with an ownership share of 33%.
As of July 11, 2024, Karsten Fjordside Poulsen is registered as an owner of REMEDY KOMPLEMENTAR APS with an ownership share of 33%.
As of July 11, 2024, Mikkel Mirsbach Rasmussen is registered as an owner of REMEDY KOMPLEMENTAR APS with an ownership share of 33%.
REMEDY KOMPLEMENTAR APS has published its interim report for the period April 13, 2023 – December 31, 2023.
About REMEDY KOMPLEMENTAR APS
REMEDY KOMPLEMENTAR APS is a Danish company of the type Anpartsselskab based in Ry, founded in 2023. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Karsten Fjordside Poulsen, Mikkel Mirsbach Rasmussen and Steffen Ulsø Knudsen. The company is owned by Steffen Ulsø Knudsen, Karsten Fjordside Poulsen and Mikkel Mirsbach Rasmussen. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 3,852 and a net result of DKK 2,682 compared with DKK 1,377 the year before. Equity in the 2025 report amounted to DKK 43,800.